(Q43281145)

18 November 2017

title

Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

18 November 2017

0 references

1 reference

2

Marc Decramer

1 reference

18 November 2017

Bartolome Celli

1

1 reference

18 November 2017

Steven Kesten

3

1 reference

18 November 2017

Dacheng Liu

4

1 reference

18 November 2017

Sunil Mehra

5

1 reference

18 November 2017

Donald P Tashkin

6

1 reference

18 November 2017

UPLIFT Study Investigators

7

1 reference

18 November 2017

language of work or name

English

0 references

publication date

3 September 2009

1 reference

American Journal of Respiratory and Critical Care Medicine

18 November 2017

published in

1 reference

18 November 2017

volume

180

1 reference

18 November 2017

issue

10

1 reference

18 November 2017

page(s)

948-955

1 reference

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

Improvement in Resting Inspiratory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes *

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

Withdrawal from treatment as an outcome in the ISOLDE study of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

Methodological issues in therapeutic trials of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

The INSPIRE study: influence of prior use and discontinuation of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0876OC

10.1164/RCCM.200906-0876OC

21 January 2018

Identifiers

DOI

1 reference

18 November 2017

1 reference